September 4th 2024
According to some reports, the draft rule imposes strict limitations on telehealth prescriptions even as advocates push for extension of current flexibilities.
Dr. Patrick P. Gleason Addresses the Impact of Out-of-Pocket Costs on Adherence and Outcomes
March 28th 2012Patrick P. Gleason, PharmD, Director of Clinical Outcomes Assessment, Prime Therapeutics, discusses the rates at which patients will not follow a prescribed therapeutic plan due to cost-sharing. Specifically, patients starting multiple sclerosis, rheumatoid arthritis, and oral oncology medication regimens with more than a $100 cost-share will be less likely to start the drug therapy.
Read More
Reducing Long-Term Cost by Transforming Primary Care: Evidence From Geisinger's Medical Home Model
ProvenHealth Navigator, Geisinger's version of advanced patient-centered medical homes, is associated with significant savings in total cost of care over time.
Read More
Dr. Randell Correia Suggests How to Control Costs in Specialty Pharmacy
March 13th 2012Randell "RJ" Correia, PharmD, Senior Vice President, Pharmacy Services, Optum Rx, addresses the rapid rise of specialty pharmacy spending. Dr. Correia discusses the possible complications health reform exchanges may cause and the impact they will have on the future of pharmacy benefit drug management.
Read More
Dr. Bimal Patel Discusses the Rising Costs of Generic Drugs
March 9th 2012Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact's work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.
Read More
Optimal Approach to Improving Trauma Triage Decisions: A Cost-Effectiveness Analysis
To set priorities for quality improvement in trauma triage, we compared the cost-effectiveness of current practice with interventions to improve physician adherence to clinical guidelines.
Read More
Systematic Review of the Impact of Worksite Wellness Programs
Analysis of studies of worksite wellness programs suggested mixed impact on health-related behaviors and cost, with insufficient evidence regarding absenteeism and mental health.
Read More
Economic Evaluation of Plerixafor for Stem Cell Mobilization
Use of granulocyte colony-stimulating factor plus plerixafor for stem cell mobilization is cost-effective in pretreated patients with non-Hodgkin lymphoma.
Read More
The Impact of Hospitalists on Length of Stay and Costs: Systematic Review and Meta-Analysis
In this systematic review and meta-analysis, we found that hospitalists reduce hospital length of stay without increasing costs.
Read More
Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
Read More